At Radisens Diagnostics, we're building the next generation of diagnostic haematology platforms. Find out about this growing marketplace, or learn more about our revolutionary technology.
For Investors
No affordable diagnostic device on the market offers robust mobility combined with hematology analysis at point-of-care. The diagnostics industry is scrambling to serve this US healthcare-driven need for decentralised diagnostics, a market worth US$36bn annually.
The Technology
Radisens is leading a step-change towards handheld instruments for medical practitioners in outpatient and emergency departments, doctors' offices and clinics. We're creating one generic platform offering multiple tests with just a few drops of blood.